Dexamethasone for Chemotherapy‐Induced Nausea and Vomiting Prevention in Pediatric Patients: International Consensus

Puntos clave

• This research aims to provide consensus guidance on using dexamethasone as an antiemetic for pediatric patients undergoing chemotherapy.
• Delphi panel consensus statements.
• Focus on chemotherapy-naïve pediatric patients.
• Consideration of moderate and highly emetogenic chemotherapy (MEC and HEC).
• Dexamethasone is recommended for nausea and vomiting prevention.
• Consensus highlights its effective role as an antiemetic in pediatric chemotherapy.